Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
Amir Shlomai, Ype P. de Jong, Charles M. Rice
Seminars in Cancer Biology (2014) Vol. 26, pp. 78-88
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR‐23a‐3p and Up‐regulate Programmed Death Ligand 1 Expression in Macrophages
Jiatao Liu, Lulu Fan, Hanqing Yu, et al.
Hepatology (2019) Vol. 70, Iss. 1, pp. 241-258
Open Access | Times Cited: 382
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Yaojie Fu, Shanshan Liu, Shan Zeng, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 339
The yin and yang of evasion and immune activation in HCC
Oxana V. Makarova‐Rusher, José Medina‐Echeverz, Austin G. Duffy, et al.
Journal of Hepatology (2015) Vol. 62, Iss. 6, pp. 1420-1429
Open Access | Times Cited: 271
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances
Renumathy Dhanasekaran, Salome Bandoh, Lewis R. Roberts
F1000Research (2016) Vol. 5, pp. 879-879
Open Access | Times Cited: 194
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
Simmone D’souza, Keith C.K. Lau, Carla S. Coffin, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 38, pp. 5759-5783
Open Access | Times Cited: 190
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
Rui Xing, Jinping Gao, Qi Cui, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 127
Hepatitis B Virus-Associated Hepatocellular Carcinoma
Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxı̀
Viruses (2022) Vol. 14, Iss. 5, pp. 986-986
Open Access | Times Cited: 116
Co-infections, inflammation and oncogenesis: Future directions for EBV research
Alan B. Rickinson
Seminars in Cancer Biology (2014) Vol. 26, pp. 99-115
Closed Access | Times Cited: 172
Molecular mechanisms of the preventable causes of cancer in the United States
Erica A. Golemis, Paul Scheet, Tim N. Beck, et al.
Genes & Development (2018) Vol. 32, Iss. 13-14, pp. 868-902
Open Access | Times Cited: 141
Sex-Dependent Outcome of Hepatitis B and C Viruses Infections: Synergy of Sex Hormones and Immune Responses?
Anna Ruggieri, Maria Cristina Gagliardi, Simona Anticoli
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 141
Sex Hormone-Dependent Physiology and Diseases of Liver
Paulina Kur, Agnieszka Kolasa, Kamila Misiakiewicz-Has, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 8, pp. 2620-2620
Open Access | Times Cited: 130
Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?
Youngmin A. Lee, Scott L. Friedman
Antiviral Research (2014) Vol. 107, pp. 23-30
Open Access | Times Cited: 126
Hepatocellular carcinoma in Asia: Prevention strategy and planning
Sara Ashtari
World Journal of Hepatology (2015) Vol. 7, Iss. 12, pp. 1708-1708
Open Access | Times Cited: 111
Role of Gut Microbiota in Hepatocarcinogenesis
Haripriya Gupta, Gi Soo Youn, Min Jea Shin, et al.
Microorganisms (2019) Vol. 7, Iss. 5, pp. 121-121
Open Access | Times Cited: 108
The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha‐fetoprotein
Suchandrima Ghosh, Sayantani Bhowmik, Swagata Majumdar, et al.
International Journal of Cancer (2020) Vol. 147, Iss. 10, pp. 2934-2947
Open Access | Times Cited: 106
Hepatitis C Virus Infection of Cultured Human Hepatoma Cells Causes Apoptosis and Pyroptosis in Both Infected and Bystander Cells
Hassan M. Kofahi, Nathan Taylor, Kensuke Hirasawa, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 89
When Hepatitis B Virus Meets Interferons
Guangyun Tan, Hongxiao Song, Fengchao Xu, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 85
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 20, pp. 2416-2429
Open Access | Times Cited: 80
Atezolizumab and Bevacizumab for Hepatocellular Carcinoma: Mechanism, Pharmacokinetics and Future Treatment Strategies
Xiufeng Liu, Yi Lu, Shukui Qin
Future Oncology (2021) Vol. 17, Iss. 17, pp. 2243-2256
Open Access | Times Cited: 57
Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression
Zongqiang Hu, Yanfeng Yin, Jie Jiang, et al.
Journal of Gastrointestinal Oncology (2022) Vol. 13, Iss. 2, pp. 754-767
Open Access | Times Cited: 49
Magnetic-Manipulated NK Cell Proliferation and Activation Enhance Immunotherapy of Orthotopic Liver Cancer
Han Jiang, Hao Fu, Min Tao, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 24, pp. 13147-13160
Closed Access | Times Cited: 37
A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma
Maria Effenberger, Silvio Waschina, Christina Bronowski, et al.
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 23
The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates
Agustiningsih Agustiningsih, Muhammad Rezki Rasyak, Turyadi Turyadi, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 1, pp. 120-134
Open Access | Times Cited: 12
Hepatocellular Carcinoma
Marie‐Annick Buendia, Christine Neuveut
Cold Spring Harbor Perspectives in Medicine (2015) Vol. 5, Iss. 2, pp. a021444-a021444
Open Access | Times Cited: 91
Interferon-Inducible Cholesterol-25-Hydroxylase Inhibits Hepatitis C Virus Replication via Distinct Mechanisms
Yongzhi Chen, Shanshan Wang, Zhaohong Yi, et al.
Scientific Reports (2014) Vol. 4, Iss. 1
Open Access | Times Cited: 88
Page 1 - Next Page

Scroll to top